MED17 Antibody

Code CSB-PA013650GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
MED17
Alternative Names
77-KD subunit antibody; Activator recruited cofactor 77 kDa component antibody; Activator-recruited cofactor 77 kDa component antibody; ARC77 antibody; Cofactor required for Sp1 transcriptional activation subunit 6 antibody; cofactor required for Sp1 transcriptional activation, subunit 6, 77kDa antibody; CRSP complex subunit 6 antibody; CRSP6 antibody; CRSP77 antibody; DRIP80 antibody; med17 antibody; MED17_HUMAN antibody; Mediator complex subunit 17 antibody; Mediator of RNA polymerase II transcription subunit 17 antibody; Mediator of RNA polymerase II transcription subunit 17, S cerevisiae, homolog of antibody; Thyroid hormone receptor-associated protein complex 80 kDa component antibody; Thyroid hormone receptor-associated protein, 80-KD subunit antibody; Transcriptional coactivator CRSP77 antibody; Trap80 antibody; VITAMIN D RECEPTOR-INTERACTING PROTEIN, 80-KD antibody; Vitamin D3 receptor-interacting protein complex 80 kDa component antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human MED17
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
Gene References into Functions
  1. These findings suggest that hMED17 may play essential roles in switching between transcription and nucleotide excision repair. PMID: 25482373
  2. TRAP80 is a selective regulator of hepatic lipogenesis and is required for LXR-dependent SREBP-1c activation. PMID: 25437875
  3. Studies indicate that the activation domain of p53 (p53AD) binds directly to the MED17 subunit of Mediator, whereas the p53 C-terminal domain (p53CTD) binds the MED1 subunit. PMID: 21326907
  4. the p. L371P mutation in MED17 is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy with poor myelination. PMID: 20950787
Involvement in disease
Microcephaly, postnatal progressive, with seizures and brain atrophy (MCPHSBA)
Subcellular Location
Nucleus.
Protein Families
Mediator complex subunit 17 family
Tissue Specificity
Ubiquitous.
Database Links

HGNC: 2375

OMIM: 603810

KEGG: hsa:9440

STRING: 9606.ENSP00000251871

UniGene: Hs.444931

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*